Serum SCCA, Cyfra 21-1, EGFR and cyclin D1 levels in patients with oral squamous cell carcinoma

International Journal of Biological Markers

Volumn 25, Issue 2, 2010, Pages 93-98

  Feng, Xiao Yu ^a   Li, Jian Hua ^a   Li, Jin Zhong ^a   Li, Hua ^a   Han, Zheng Xue ^a   Xing, Ru Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin D1; Cyfra 21 1; EGFR; Oral squamous cell carcinoma; SCCA

Indexed keywords

CYCLIN D1; CYTOKERATIN 19 FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; SQUAMOUS CELL CARCINOMA ANTIGEN; ANTIGEN CYFRA21.1; CYTOKERATIN 19; EGFR PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TISSUE DIFFERENTIATION; VENOUS BLOOD; BLOOD; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; PATHOLOGY; PROGNOSIS; REHABILITATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; HUMANS; KERATIN-19; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SERPINS;

EID: 77954902079     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500206     Document Type: Article

References (28)

1. Mignogna MD, Fedele S, Lo Russo L. The World Cancer Report and the burden of oral cancer. J Cancer Prev 2004; 13: 39-42.
2. Kademani D. Oral cancer. Mayo Clin Proc 2007; 82: 878-87.
3. Takada M, Masuda N, Matsuura E, et al. Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer 1995; 71: 160-5.
4. Inal E, Laçin M, Asal K, et al. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Kulak Burun Bogaz Ihtis Derg 2004; 12: 23-30.
5. Scully C, Bagan JV. Recent advances in oral oncology. Oral Oncology 2007; 43: 107-15.
6. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM classification of malignant tumoursm 5th edition. New York: Wiley-Liss Inc. 1997; 20-4.
7. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press 2005; 168-75.
8. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 1621-8.
9. Kimura Y, Fujieda S, Takabayashi T, et al. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma. Cancer Lett 2000; 155: 163-8. (Pubitemid 30259130)
10. Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol Allied Sci 1998; 23: 82-6.
11. Büntzel J, Hornig A, Glatzel M, et al. Tumor markers and lymphatic metastasis in head and neck cancer patients. Anticancer Res 2005; 25: 1539-42.
12. Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53: 61-6. (Pubitemid 23019377)
13. Buccheri G, Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 2001; 34 (Suppl 2): S65-9.
14. Zhong LP, Zhu HG, Zhang CP, Chen WT, Zhang ZY. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2007; 36: 230-4.
15. Deng YF, Chen P, Lin YZ, et al. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma. J Laryngol Otol 2003; 117: 190-4. (Pubitemid 36286643)
16. Banal A, Hacene K, Berthelot-Ruff E, Mahé E, Fontana X, Pichon MF. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours. Tumour Biol 2001; 22: 27-35.
17. Pradier O, Hille A, Schmiberger H, Hess CF. Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1. Cancer Radiother 2002; 6: 15-21. (Pubitemid 34169501)
18. Zlobec I, Vuong T, Hayashi S, et al. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy. Br J Cancer 2007; 96: 793-800.
19. Rautava J, Jee KJ, Miettinen PJ, et al. ERBB receptors in developing, dysplastic and malignant oral epithelia. Oral Oncol 2008; 44: 227-35. (Pubitemid 351249190)
20. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: A TMA-based immunohistochemical analysis. Oral Oncol 2007; 43: 193-8.
21. Ekberg T, Nestor M, Engström M, et al. Expression of EGFR, HER2, HER3 and HER4 in metastatic squamous cell carcinoma of the oral cavity and base of tongue. Int J Oncol 2005; 26: 1177-85.
22. Ch'ng S, Low I, Ng D, et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol 2008; 39: 344-9.
23. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A, Feinmesser R. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral Oncol 2004; 40: 532-7. (Pubitemid 38296840)
24. Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993; 3: 5-10.
25. Bova RJ, Quinn DI, Nankervis JS, et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999; 5: 2810-9.
26. Liu B, Ren Z, Shi Y, Guan C, Pan Z, Zong Z. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas. Laryngoscope 2008; 18: 1976-80.
27. Fu ZJ, Ma ZY, Wang QR, et al. Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis 2008; 5: 887-92.
28. Glazer CA, Chang SS, Ha PK, Califano JA. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncology 2009; 5: 440-6.